Literature DB >> 23232638

Risk factors and incidence of acute pyogenic cholangitis.

Yun-Sheng Qin1, Qi-Yong Li, Fu-Chun Yang, Shu-Sen Zheng.   

Abstract

BACKGROUND: Acute cholangitis varies from mild to severe form. Acute suppurative cholangitis (ASC), the severe form of acute cholangitis, is a fatal disease and requires urgent biliary decompression. Which patients are at a high risk of ASC and need emergency drainage is still unclear. The present study aimed to identify the factors for determining early-stage ASC and distinguishing ASC from acute cholangitis.
METHODS: We analyzed 359 consecutive patients with acute cholangitis who had been admitted to the First Affiliated Hospital, Zhejiang University School of Medicine from January 2004 to May 2011. Emergency endoscopic retrograde cholangiopancreatography (ERCP) was carried out in all patients to decompress or clear the stones by experienced endoscopists. Clinical and therapeutic data were collected, and univariate and multivariate analyses were performed to identify the potential risk factors of ASC.
RESULTS: Of the 359 patients, 1 was excluded because of failure of ERCP drainage. Of the remaining 358 patients with an average age of 62.7 years (range 17-90), 162 were diagnosed with ASC, and 196 with non-ASC. ENBD catheters were placed in 343 patients (95.8%), of whom 182 patients had stones removed at the same time, and plastic stent was placed in 25 patients (7.0%). Clinical conditions were improved quickly after emergency biliary drainage in all patients. Complications were identified in 11 patients (3.1%): mild pancreatitis occurred in 8 patients and hemorrhage in 3 patients. There was no mortality. Univariate analysis showed that several variables were associated with ASC: age, fever, decreased urine output, hypotension, tachycardia, abnormal white blood cell count (WBC), low platelet, high C reactive protein (CRP), and duration of the disease. Multivariate analysis revealed that advanced age, hypotension, abnormal WBC, high CRP, and duration of the disease were independent risk factors for ASC.
CONCLUSIONS: This study demonstrates that advanced age, hypotension, abnormal WBC, high CRP, and long duration of antibiotic therapy are significantly associated with ASC. We recommend decompression by ERCP should be carried out in patients as early as possible.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23232638     DOI: 10.1016/s1499-3872(12)60240-9

Source DB:  PubMed          Journal:  Hepatobiliary Pancreat Dis Int


  6 in total

1.  Comparison of acute cholangitis with or without common bile duct dilatation.

Authors:  Minoru Tomizawa; Fuminobu Shinozaki; Rumiko Hasegawa; Yoshinori Shirai; Yasufumi Motoyoshi; Takao Sugiyama; Shigenori Yamamoto; Naoki Ishige
Journal:  Exp Ther Med       Date:  2017-04-28       Impact factor: 2.447

Review 2.  Cholangitis: Diagnosis, Treatment and Prognosis.

Authors:  Amir Houshang Mohammad Alizadeh
Journal:  J Clin Transl Hepatol       Date:  2017-09-07

3.  Therapeutic experience of 289 elderly patients with biliary diseases.

Authors:  Zong-Ming Zhang; Zhuo Liu; Li-Min Liu; Chong Zhang; Hong-Wei Yu; Bai-Jiang Wan; Hai Deng; Ming-Wen Zhu; Zi-Xu Liu; Wen-Ping Wei; Meng-Meng Song; Yue Zhao
Journal:  World J Gastroenterol       Date:  2017-04-07       Impact factor: 5.742

4.  Dynamic Monitoring of sTREM-1 and Other Biomarkers in Acute Cholangitis.

Authors:  Jiahui Jiang; Xiaolei Wang; Tongtong Cheng; Mingyue Han; Xinxin Wu; Haitong Wan
Journal:  Mediators Inflamm       Date:  2020-05-15       Impact factor: 4.711

5.  Diagnostic Inflammation Biomarkers for Prediction of 30-Day Mortality Rate in Acute Cholangitis.

Authors:  Omer Al-Yahri; Raed M Al-Zoubi; Azza Alam Elhuda; Amina Ahmad; Mahmood Al Dhaheri; Sherif Abdelaziem; Mustafa Alwani; Ahmad R Al-Qudimat; Ahmad Zarour
Journal:  Int J Surg Protoc       Date:  2022-03-02

6.  Laparoscopic versus Conventional Surgery for Acute Cholangitis of Severe Type: A Systematic Review of Randomized Controlled Trials.

Authors:  Fang Zhang; Jianjiang Huang; Jie Yang; Yuyu Wang; Bin Qiu
Journal:  Comput Math Methods Med       Date:  2022-06-16       Impact factor: 2.809

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.